Panel Series
Red light therapy masks are not a direct melanin-reducing treatment, but they may support clearer skin tone through three indirect mechanisms: reducing the inflammation that triggers post-inflammatory hyperpigmentation (PIH), stimulating the cellular repair processes that help skin renew more evenly, and supporting the structural integrity of the dermal-epidermal junction relevant to persistent melasma. Red wavelengths (630 nm) and near-infrared (830 nm) work through mitochondrial pathways to enhance cellular energy and collagen synthesis; amber (590 nm) has been studied specifically for effects on skin tone and redness. Results are gradual and work best as part of a broader approach that includes consistent sun protection and, where appropriate, pigment-targeting topicals.
Understanding Hyperpigmentation
Hyperpigmentation describes areas of skin that appear darker than surrounding tissue due to excess melanin deposition. It is not a single condition — the type, depth, and persistence of pigmentation vary significantly, and understanding the difference matters for choosing the right approach.
Post-inflammatory hyperpigmentation (PIH)
PIH develops after the skin experiences inflammation — from acne, injury, irritation, or cosmetic procedures. The inflammatory response activates melanocytes to produce excess pigment as part of healing. The result is a dark spot that lingers after the original trigger has resolved. PIH is generally superficial and responds reasonably well to consistent treatment because it sits in the upper layers of the skin where cell turnover can gradually clear it.
Melasma
Melasma is more complex. It is driven by a combination of UV exposure, heat, and hormonal signaling — all of which can independently stimulate melanocytes. What distinguishes melasma from PIH is that it frequently involves disruption of the basement membrane (the structural layer between the epidermis and dermis), allowing melanocytes and melanin to penetrate into deeper dermal layers where standard topical treatments cannot reach effectively. This is why melasma tends to be more persistent and more likely to recur.
Solar lentigines and general sun damage
Sun-induced pigmentation from cumulative UV exposure tends to be superficial and responds well to antioxidant-rich topicals, retinoids, and consistent SPF. Red light therapy may contribute to the overall skin renewal environment but is a supportive tool rather than a primary treatment for sun damage.
How Red Light Therapy May Support Skin Tone
Red light therapy masks do not directly inhibit melanin production or break down existing melanin — they do not work like hydroquinone, kojic acid, niacinamide, or vitamin C in that sense. Their contribution to improved skin tone is indirect, operating through three mechanisms.
Reducing inflammation — the PIH trigger
Photobiomodulation has well-documented anti-inflammatory effects, modulating pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α. Because PIH is driven by the same inflammatory cascade that follows acne and skin irritation, reducing post-inflammatory signaling may help limit the melanocyte activation that causes dark spots in the first place. A review by Avci et al. in Seminars in Cutaneous Medicine and Surgery summarized photobiomodulation's anti-inflammatory mechanisms across skin applications.
Supporting skin repair and cell turnover
Red light (630–660 nm) stimulates fibroblast activity and supports collagen synthesis, which contributes to healthier overall skin structure and more efficient cellular renewal. As skin turns over more efficiently, superficial pigment clears more quickly as part of the normal epidermal renewal cycle. This is a gradual process — it supports the conditions for clearing rather than directly removing pigment.
Structural support relevant to melasma
Near-infrared wavelengths (830 nm) penetrate to the dermis, where they may support the structural proteins that maintain the basement membrane. Research has shown that basement membrane disruption is commonly observed in melasma and contributes to deeper, more persistent pigmentation. By supporting dermal collagen and structural integrity, NIR light may help reinforce the dermal-epidermal junction — though this remains an area where more targeted research is needed.
The hover design and heat management
Heat is a documented trigger for melasma. Devices that sit directly against the face can generate localized skin temperature increases during sessions. The MitoGLOW's hover design — which maintains airflow between the LED array and the skin — is specifically relevant here, as it reduces heat accumulation during sessions. For users managing melasma, this design consideration is more than cosmetic.
Wavelengths Most Relevant to Pigmentation
| Wavelength | Mechanism relevant to pigmentation | Evidence level |
|---|---|---|
| 590 nm (amber) | Vascular tone, surface anti-inflammatory, redness reduction; studied for skin tone uniformity | Emerging — limited RCTs |
| 630 nm (red) | Anti-inflammatory, fibroblast stimulation, cell renewal support; reduces post-inflammatory redness | Strong (multiple RCTs for skin rejuvenation) |
| 830 nm (NIR) | Deep dermal support, collagen synthesis, basement membrane structural support | Strong (structural anti-aging); emerging for melasma specifically |
What to Expect: Realistic Outcomes by Pigmentation Type
| Pigmentation type | Red light therapy role | Expected contribution | Essential alongside |
|---|---|---|---|
| PIH (post-acne, post-irritation) | Reduce inflammation → limit new PIH; support cell renewal | Meaningful — 6–12 weeks of consistent use | SPF daily; topical brighteners (niacinamide, vitamin C) |
| Melasma | Structural support; heat management via hover design | Supportive — dermatologist guidance essential | Strict SPF; dermatologist-managed treatment plan |
| Sun damage / lentigines | General skin renewal support | Modest — supportive within a broader routine | SPF; retinoids or targeted brightening actives |
| Acne-related redness | Direct anti-inflammatory; blue light targets bacteria | Strong — 4–8 weeks for active acne; 8–12 weeks for PIH | Consistent acne routine; SPF post-session |
Important Cautions for Darker Skin Tones
Red and near-infrared wavelengths (590–830 nm) do not stimulate melanin production and do not carry the photosensitization risks associated with UV light. They are generally well-tolerated across all Fitzpatrick skin types.
However, blue light (415–465 nm) used in acne protocols carries a documented risk of temporary hyperpigmentation on darker skin tones (Fitzpatrick III and above) in some individuals. If you have a darker skin tone or a tendency toward hyperpigmentation, use blue light modes cautiously — start with shorter sessions, monitor for any change in pigmentation, and discontinue if hyperpigmentation worsens. This is a device-specific consideration, not a blanket concern about red light therapy.
Anyone with melasma or a dermatologist-managed pigmentation condition should consult their dermatologist before incorporating any new light device into their routine.
MitoGLOW for skin tone
Four wavelengths including 590 nm amber specifically studied for tone and redness
Hover design reduces heat buildup — relevant for melasma users. FDA 510(k) cleared for acne and wrinkles. Third-party verified wavelengths.
Frequently Asked Questions
Can red light therapy masks improve hyperpigmentation?
Indirectly, yes — for PIH specifically. By reducing the inflammation that triggers melanocyte activation, and supporting the skin renewal environment, red light therapy can contribute to gradual clearing of post-inflammatory dark spots over 6–12 weeks of consistent use. It does not directly inhibit melanin production the way brightening actives do, so it works best as part of a broader approach alongside SPF and targeted topicals.
Does red light therapy work for melasma?
The evidence for melasma specifically is limited. Melasma involves deep structural changes including basement membrane disruption, making it more resistant to surface-level treatments. NIR wavelengths may provide structural support, and the hover design helps avoid heat-triggered flares, but melasma management requires dermatological oversight. Do not rely on red light therapy as a primary melasma treatment.
Can red light therapy make hyperpigmentation worse?
Red and near-infrared wavelengths do not stimulate melanin production and are generally safe across skin types. However, blue light (465 nm) can cause temporary hyperpigmentation in darker skin tones (Fitzpatrick III+) in some individuals. Heat from contact mask designs can also potentially trigger melasma flares. Monitor your skin when starting any new protocol and discontinue if pigmentation worsens.
What wavelengths help with skin tone and pigmentation?
590 nm amber has been studied specifically for redness reduction and tone uniformity. 630 nm red supports anti-inflammatory effects and skin renewal. 830 nm near-infrared provides deeper structural support. The combination in a single mask session addresses multiple aspects of skin tone simultaneously.
How long before I see results for hyperpigmentation?
For PIH, expect gradual improvement over 6–12 weeks of consistent use at 4–5 sessions per week alongside strict SPF and a complementary skincare routine. Melasma timelines are longer and less predictable. Sun damage responds slower still. Photograph progress every 2–4 weeks — changes are gradual and easy to miss without a visual reference.
Can red light therapy replace topical treatments for pigmentation?
No. Topical brightening agents (vitamin C, niacinamide, kojic acid, azelaic acid) and sunscreen are the primary evidence-based tools for managing hyperpigmentation. Red light therapy is a supportive addition to that approach, particularly for reducing the inflammatory component of PIH and supporting general skin renewal.
References:
1. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological Reviews. 2004;84(4):1155–1228. pubmed.ncbi.nlm.nih.gov/15383650
2. Kang HY, Ortonne JP. What should be considered in treatment of melasma. Annals of Dermatology. 2010;22(4):373–378. pubmed.ncbi.nlm.nih.gov/21165205
3. Avci P, Gupta A, Sadasivam M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Seminars in Cutaneous Medicine and Surgery. 2013;32(1):41–52. pmc.ncbi.nlm.nih.gov/articles/PMC4126803
4. Lee SY, Park KH, Choi JW, et al. A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation. Journal of Photochemistry and Photobiology B. 2007;88(1):51–67. pubmed.ncbi.nlm.nih.gov/17566756
5. Yi S, Ding J, Li X, et al. Efficacy and safety of 570–590 nm yellow light combined with red and infrared LED in treating facial skin photoaging. Lasers in Medical Science. 2025;40(1):435. pubmed.ncbi.nlm.nih.gov/41091280
This article discusses published scientific research and general educational information about photobiomodulation and red light therapy. It does not constitute medical advice and does not make specific claims about Mito Red Light devices. The research cited reflects independent peer-reviewed studies and does not imply that any Mito Red Light product has been evaluated, approved, or cleared by the FDA or any other regulatory body for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Individual results vary. Consult a qualified healthcare professional before beginning any light therapy protocol, particularly if you have a pre-existing medical condition, are pregnant, or are taking photosensitising medications.
For hyperpigmentation and uneven tone, a mask with multiple wavelengths — including yellow (590 nm) for redness and near-infrared for cellular repair — will outperform single-wavelength devices. The MitoGLOW™ LED mask for hyperpigmentation covers all four wavelengths in one hands-free session. Browse LED face masks →
Mito Red Light products are general wellness devices. They are not medical devices and have not been evaluated, cleared, or approved by the FDA or any regulatory body for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any references to peer-reviewed research or clinical studies on this page describe findings from independent scientific literature and do not imply that Mito Red Light devices have been studied, tested, or proven effective for any specific condition. Always consult a qualified healthcare provider before beginning any new wellness routine, particularly if you have a medical condition or are taking medication.
Related articles
More from the skin health & anti-aging knowledge cluster